ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended						9 Months Ended		12 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Oct. 31, 2024
Debt Instrument [Line Items]
Working capital deficit	$ 3,748,008						$ 3,748,008
Accumulated deficit	11,279,023						11,279,023		$ 10,797,216
Cash	1,895						1,895		36,466
Short term note payable	2,719,587						2,719,587
Deferred tax liability	320,329						320,329
Net loss	95,537	$ 124,010	$ 262,260	$ 423,598	$ 325,102	$ 466,675	481,807
Net cash used in operating activity							124,571	$ 573,611
Net revenue							47,000	47,000
Increase in net revenue							96,000	143,000
Liquidation sale							80,000
Net loss							482,000	1,215,000
Cash used in operating activities							125,000	574,000
Inventory	0						0		133,775
Goodwill	1,936,020						1,936,020
Impairment charge							0	0
Amortization of Debt Issuance Costs and Discounts							840	15,500
Accrued warranty liability							0		$ 1,288
Sales and marketing expenses				$ 9,733			17,403	66,144
Product development expenses							$ 4,268	$ 76,454
Share-Based Payment Arrangement, Option [Member]
Debt Instrument [Line Items]
Total number of potentially dilutive common stock							208,288	408,288
Warrant [Member]
Debt Instrument [Line Items]
Total number of potentially dilutive common stock							199,733	199,733
Preferred B-1 Stock [Member]
Debt Instrument [Line Items]
Total number of potentially dilutive common stock							15,000	15,000
Common Stocks [Member]
Debt Instrument [Line Items]
Total number of potentially dilutive common stock							999,900	999,900
Unsecure Promissory Note [Member] | Subsequent Event [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount										$ 125,914
Debt Instrument, Interest Rate, Stated Percentage										7.00%